Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-G21 and 68Ga-G23 PET Imaging in Prostate Cancer
NCT07363382Phase 2Recruiting
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of 68Ga-G21, 68Ga-G23 in prostate cancer (PCa), sponsored by The First Hospital of Fujian Medical University. Started Dec 2025; status: recruiting.
02
Drugs
68Ga-G2168Ga-G23
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07363382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07363382.